List of Tables
Table 1. Global Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Cell Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cell Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Cell Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Cell Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Cell Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Cell Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy as of 2024)
Table 15. Global Cell Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Cell Therapy Market
Table 17. Global Cell Therapy Companies Product & Service
Table 18. Global Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Gilead Sciences Corporation Information
Table 20. Gilead Sciences Description and Business Overview
Table 21. Gilead Sciences Cell Therapy Product
Table 22. Gilead Sciences Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Gilead Sciences Revenue Proportion of Cell Therapy by Product in 2024
Table 24. Gilead Sciences Revenue Proportion of Cell Therapy by Application in 2024
Table 25. Gilead Sciences Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 26. Gilead Sciences Recent Developments
Table 27. Novartis Corporation Information
Table 28. Novartis Description and Business Overview
Table 29. Novartis Cell Therapy Product
Table 30. Novartis Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Novartis Revenue Proportion of Cell Therapy by Product in 2024
Table 32. Novartis Revenue Proportion of Cell Therapy by Application in 2024
Table 33. Novartis Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 34. Novartis Recent Developments
Table 35. Osiris Corporation Information
Table 36. Osiris Description and Business Overview
Table 37. Osiris Cell Therapy Product
Table 38. Osiris Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Osiris Revenue Proportion of Cell Therapy by Product in 2024
Table 40. Osiris Revenue Proportion of Cell Therapy by Application in 2024
Table 41. Osiris Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 42. Osiris Recent Developments
Table 43. Vericel Corporation Corporation Information
Table 44. Vericel Corporation Description and Business Overview
Table 45. Vericel Corporation Cell Therapy Product
Table 46. Vericel Corporation Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Vericel Corporation Revenue Proportion of Cell Therapy by Product in 2024
Table 48. Vericel Corporation Revenue Proportion of Cell Therapy by Application in 2024
Table 49. Vericel Corporation Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 50. Vericel Corporation Recent Developments
Table 51. Vcanbio Corporation Information
Table 52. Vcanbio Description and Business Overview
Table 53. Vcanbio Cell Therapy Product
Table 54. Vcanbio Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Vcanbio Revenue Proportion of Cell Therapy by Product in 2024
Table 56. Vcanbio Revenue Proportion of Cell Therapy by Application in 2024
Table 57. Vcanbio Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 58. Vcanbio Recent Developments
Table 59. Fujifilm Cellular Dynamics Corporation Information
Table 60. Fujifilm Cellular Dynamics Description and Business Overview
Table 61. Fujifilm Cellular Dynamics Cell Therapy Product
Table 62. Fujifilm Cellular Dynamics Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Fujifilm Cellular Dynamics Revenue Proportion of Cell Therapy by Product in 2024
Table 64. Fujifilm Cellular Dynamics Revenue Proportion of Cell Therapy by Application in 2024
Table 65. Fujifilm Cellular Dynamics Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 66. Fujifilm Cellular Dynamics Recent Developments
Table 67. JCR Pharmaceuticals Corporation Information
Table 68. JCR Pharmaceuticals Description and Business Overview
Table 69. JCR Pharmaceuticals Cell Therapy Product
Table 70. JCR Pharmaceuticals Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. JCR Pharmaceuticals Revenue Proportion of Cell Therapy by Product in 2024
Table 72. JCR Pharmaceuticals Revenue Proportion of Cell Therapy by Application in 2024
Table 73. JCR Pharmaceuticals Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 74. JCR Pharmaceuticals Recent Developments
Table 75. Beike Biotechnology Corporation Information
Table 76. Beike Biotechnology Description and Business Overview
Table 77. Beike Biotechnology Cell Therapy Product
Table 78. Beike Biotechnology Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Beike Biotechnology Revenue Proportion of Cell Therapy by Product in 2024
Table 80. Beike Biotechnology Revenue Proportion of Cell Therapy by Application in 2024
Table 81. Beike Biotechnology Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 82. Beike Biotechnology Recent Developments
Table 83. Golden Meditech Corporation Information
Table 84. Golden Meditech Description and Business Overview
Table 85. Golden Meditech Cell Therapy Product
Table 86. Golden Meditech Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Golden Meditech Revenue Proportion of Cell Therapy by Product in 2024
Table 88. Golden Meditech Revenue Proportion of Cell Therapy by Application in 2024
Table 89. Golden Meditech Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 90. Golden Meditech Recent Developments
Table 91. Guanhao Biotech Corporation Information
Table 92. Guanhao Biotech Description and Business Overview
Table 93. Guanhao Biotech Cell Therapy Product
Table 94. Guanhao Biotech Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Guanhao Biotech Revenue Proportion of Cell Therapy by Product in 2024
Table 96. Guanhao Biotech Revenue Proportion of Cell Therapy by Application in 2024
Table 97. Guanhao Biotech Revenue Proportion of Cell Therapy by Geographic Area in 2024
Table 98. Guanhao Biotech Recent Developments
Table 99. North America Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Cell Therapy Key Raw Materials, Industry Status and Trend
Table 120. Cell Therapy Key Raw Materials and Upstream Suppliers
Table 121. Cell Therapy Clients Status and Trend
Table 122. Cell Therapy Typical Clients
Table 123. Cell Therapy Distributors
Table 124. Cell Therapy Market Trends
Table 125. Cell Therapy Market Drivers
Table 126. Cell Therapy Market Challenges
Table 127. Cell Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell Therapy Product Picture
Figure 2. Global Cell Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Cell Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Stem Cell Product Picture
Figure 5. Non-Stem Cell Product Picture
Figure 6. Global Cell Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Cell Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Cell Therapy Report Years Considered
Figure 11. Global Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 13. Global Cell Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 14. Global Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 15. Global Cell Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 16. Global Cell Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 17. Stem Cell of Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 18. Non-Stem Cell of Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 19. Cell Therapy Revenue Share by Company (2024)
Figure 20. Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Stem Cell Revenue Proportion by Company in 2024
Figure 22. Non-Stem Cell Revenue Proportion by Company in 2024
Figure 23. North America Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 24. North America Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 25. North America Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 26. Asia-Pacific Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 27. Asia-Pacific Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 28. Asia-Pacific Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 29. Asia-Pacific Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 30. Europe Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 31. Europe Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 32. Europe Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 33. Europe Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 34. Latin America Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Latin America Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 36. Latin America Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 37. Latin America Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 38. Middle East and Africa Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Middle East and Africa Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 40. Middle East and Africa Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 41. Middle East and Africa Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 42. Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 43. Global Production Market Share of Cell Therapy Raw Materials by Region in 2024
Figure 44. Cell Therapy Distribution Channels
Figure 45. Global Cell Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 46. Global Cell Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
